Recently, British medical technology company Creavo Medical Technologies announced that it will expand its financing by US$17.5 million. The investors will be jointly led by IP Group plc and Coutts Private Bank. Other investors include the original shareholder University of Leeds (Leeds University, UK) and Europe. And new shareholders of China's private equity institutions Parkwalk Advisors and Puhua Capital Ltd (Puhua Capital). The investment will continue to be used to support Creavo's business strategy, team building, and to promote its proprietary medical diagnostics technology, the Magnetocardiogram (MCG).
Founded in 2014, Creavo specializes in the commercial development of advanced sensing technologies for biomagnetic images of human organs for the detection and display of organ magnetic images to aid in disease diagnosis. This organ magnetic map sensing technology is the result of 10 years of research through the team of professors of the University of Leeds, Varcoe. Its core patented product is an electrocardiographic device that can be deployed urgently to detect, display and store electromagnetic fluctuations caused by cardiac activity by detecting magnetic heart maps (MCG).
(Source: Creavo Official YouTube)
Summer Safety Clothing,Summer Safety Vest,Summer Safety Shirt
Ningbo Staneex Imp. & Exp. Co., Ltd. , https://www.staneex.com